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Summary
Genetic anticipation, described by earlier age of onset (AOO) and more aggressive symptoms in
successive generations, is a phenomenon noted in certain hereditary diseases. Its extent may vary
between families and/or between mutation sub-types known to be associated with the disease
phenotype. In this paper, we posit a Bayesian approach to infer genetic anticipation under flexible
random effects models for censored data that capture the effect of successive generations on AOO.
Primary interest lies in the random effects. Misspecifying the distribution of random effects may
result in incorrect inferential conclusions. We compare the fit of four candidate random effects
distributions via Bayesian model fit diagnostics. A related statistical issue here is isolating the
confounding effect of changes in secular trends, screening and medical practices that may affect
time to disease detection across birth cohorts. Using historic cancer registry data, we borrow from
relative survival analysis methods to adjust for changes in age-specific incidence across birth
cohorts. Our motivating case-study comes from a Danish cancer register of 124 families with
mutations in mismatch repair genes known to cause hereditary non-polyposis colorectal cancer,
also called Lynch syndrome. We find evidence for a decrease in AOO between generations in this
study. Our model predicts family level anticipation effects which are potentially useful in genetic
counseling clinics for high risk families.
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Genetic anticipation is a phenomenon noted in certain hereditary diseases where succeeding
generations have decreased age of onset (AOO). It is hypothesized for some familial
diseases in which high-penetrance mutations have been identified (Tabori et al., 2007;
Nilbert et al., 2009). Data to test for anticipation can be retrospective in nature, where paired
data on AOOs for affected parents are compared to their affected children. Appropriate
statistical techniques have been developed to adjust for truncation bias, as younger subjects
have not experienced their entire “at-risk” period when the data are ascertained (Huang and
Vieland, 1997; Rabinowitz and Yang, 1999). See Boonstra et al. (2010) for a review of
testing for anticipation with parent-child pair data.
Alternatively, all identified and obligate mutation carriers in high-risk families may be
prospectively followed till disease diagnosis or censoring. Standard regression models for
censored data allow for estimation of a generational effect on AOO (Hsu et al., 2000). Using
data on affected and unaffected family members is a more powerful approach than the naive
analysis of parent-child pairs. Robust variance estimates (Daugherty et al., 2005) or random
intercepts (Larsen et al., 2009) can account for within-family correlation. If heterogeneity in
anticipation exists across carrier families, use of a random slope corresponding to generation
may be more appropriate. In this paper we evaluate this random intercept and slope model in
the presence of observed and unmeasured familial heterogeneity under a prospective design.
Normality of the random effects is often assumed for convenience. However, there may be
heterogeneity in anticipation across mutation subtypes; it is natural to explore models that
are able to capture this variation. A latent mixture model can also be envisioned in which the
random effects distribution adapts to latent heterogeneity not directly attributable to
measured mutation subtypes. Estimates of fixed effects are relatively robust to
misspecification of the random effects distribution (Butler and Louis, 1992; Verbeke and
Lesaffre, 1997; Neuhaus et al., 2010), but estimates of the random effects themselves are
sensitive to model choice (Verbeke and Molenberghs, 2000). When the inferential focus is
on the latter, correct specification and appropriate model diagnostic tools become critical.
Although individual predictions of the random effects can vary with the assumed
distribution, McCulloch and Neuhaus (2010) recently showed that an aggregate measure of
predictive accuracy is minimally affected by distributional misspecifications. Our interest is
in both the individual and aggregate level, so proper elucidation of the random effects
distribution remains an important statistical and biological issue.
There has been substantial work on robust modeling of the random effects. Magder and
Zeger (1996) use a smoothed version of the nonparametric mixing distribution proposed by
Laird (1978). Verbeke and Lesaffre (1996) employ a mixture of normals, using latent class
membership and the expectation-maximization (EM) algorithm to maximize the likelihood.
Kleinman and Ibrahim (1998) utilize a Dirichlet Process prior. Zhang and Davidian (2001)
assume the random effects have a smooth density determined by a user-specified tuning
parameter. We first consider a three-component mixture of normals where class membership
is attributed to the three observed mutation subtypes. We then use a mixture of normals with
latent classes, both finite mixture, and infinite. The latter is generated by a Dirichlet Process
mixture of normals (Escobar and West, 1995). These models are compared to the normal
random effects model. The Bayesian paradigm enables us to specify the hierarchical
structure on parameters through prior specification and facilitates computation through
Markov chain Monte Carlo (MCMC) techniques (Stephens, 2000; Neal, 2000). We modify
existing ideas from the Bayesian model diagnostics literature, using the deviance
information criterion (Spiegelhalter et al., 2002; Celeux et al., 2006), posterior conditional
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predictive ordinates (Geisser, 1980), and a Bayesian analogue of a scoring method proposed
by Brier (1950).
Additionally, because we have posterior draws of all model parameters and random effects,
these models can easily provide clinical quantities of interest, like the probability that a
specific family's level of anticipation exceeds a certain number of years. These tools can be
employed in counseling families at high-risk familial cancer genetics clinics.
We also address another major statistical issue in the anticipation literature for which no
proper solution has been thus far proposed. Later generations typically have access to better
medical care, more sensitive diagnostic techniques and are perhaps more knowledgeable on
lifestyle changes which decrease risk of disease. Without independently estimating and
adjusting for this cohort effect, generational changes in AOO will be the aggregate effect of
anticipation, if it exists, plus these secular changes. Using birth cohort in the model may lead
to instability in parameter estimates due to its strong correlation with generation, the primary
variable of interest. Daugherty et al. (2005) include a time-varying indicator term reflecting
a change in hazard before and after a specific year. In their case-study, upon the addition of
this indicator term to the model, the effect of anticipation lost statistical significance. Nilbert
et al. (2009) alternatively conduct analysis stratified by birth cohort. Neither of the above
two approaches is effcient as a general modeling strategy. Our solution to this problem
borrows from the concept of relative survival analysis (Ederer et al., 1961). We use external
registry data to estimate this secular change in AOO; the residual effect beyond this
estimated trend effect can then be attributed to anticipation.
1.1 A case-study of genetic anticipation in Lynch syndrome
A disease in which the presence of anticipation is disputed is Lynch Syndrome (Larsen et
al., 2009; Tsai et al., 1997). First described as a cancer family syndrome by Warthin (1913)
and later called hereditary non-polyposis colon cancer (HNPCC), Lynch syndrome (Lynch
et al. (1966)), is characterized by early onset of gastrointesinal, uterine and other cancers and
has a genetic basis in germline mutations to various mismatch repair (MMR) genes
(hMLH1, hMSH2, hMSH6 being the most common).
The dataset we use, originally considered in Larsen et al. (2009), consists of 816 individuals
from 124 families (median family size was 6 with a range of 1 to 23) ascertained over 1991–
2006 via the population-based HNPCC register in Denmark. The register contains data on
all Danish families identified with hereditary colorectal cancer. The current cohort was
defined as 124 families who went through genetic counseling and testing and were found to
carry HNPCC predisposing mutations in one of the MMR genes: hMLH1 (43 families),
hMSH2 (59), or hMSH6 (22). Families with at least two Lynch-related cancers were
included. The chosen cohort thus consists of high-risk Lynch families enriched for multiple
cancers. Consequently, all results are subject to this multiplex ascertainment bias. All “at-
risk” proven mutation carriers in these 124 families were followed prospectively, with the
event of interest being diagnosis of a Lynch-related cancer. Individuals were censored
administratively in December 2007 (202 individuals), upon detection of adenoma (a benign
tumor, 37), cancer not related to Lynch syndrome (7), or upon death (2). We assume
independent censoring in our formulation of the problem (this was likely violated for the 37
individuals who had adenoma detected, a limitation in our approach). Besides AOO and the
censoring indicator, gender, year of birth, mutation, and generation are available.
Descriptive summaries are presented in Table 1. Consistent with the regression approach to
testing anticipation, Larsen et al. propose a normal random intercept model with a fixed
effect for the difference in mean AOO between consecutive generations. We consider
extensions of this model. Lynch et al. (2006) provide an overview of various, potentially
latent, heterogeneities which may appear between Lynch families (apart from known
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mutational heterogeneity). Some examples are etiology based in recurrent versus founder
mutations, the geographical location of the affected family, and access to/compliance with
regular colonoscopy. This suggests that the anticipation effect might be more adequately
modeled as a random effect with a flexible distribution. A further benefit of this approach is
that families can get a “personalized” estimate of anticipation.
The rest of the paper is organized as follows. We introduce the original model from Larsen
et al. (2009) and then present the Bayesian specification of proposed candidate models in
Section 2. Section 3 discusses model diagnosis strategies using newly proffered criteria as
well as standard posterior predictive checks. Section 4 presents an application of the
methods to the Danish HNPCC data. Finally, we close with a discussion in Section 5.
2. Model Specification
2.1 A Random intercept model for Genetic Anticipation
Let i = 1,–, N index families and j = 1,–, ni index individuals within family i. A linear model
with random effects is given as
(1)
where Tij denotes the AOO (in years) of the jth individual in the ith family (person (i, j)), Xij
and Zij are vectors of covariates, β is a length-p vector of fixed effects, bi a length-q vector
of random effects, and εij the error term.
Tij is right-censored for some individuals at Cij, so we observe {min(tij, cij), 1 [tij ≤ cij]}.
This is equivalent to the following notational convention:
Let genij denote the generation of that individual relative to the oldest member in the
pedigree. That is, the oldest person in a pedigree is assigned gen = 1, along with his brothers,
sisters, and cousins. All members of the next generation are assigned gen = 2, and so forth.
The other two covariates used are 1[maleij] indicating gender and 1[muti = hMLH1], 1[muti
= hMSH2], and 1[muti = hMSH6] indicating mutation type. Beginning from (1), the random
intercept model proposed by Larsen et al. (2009) uses
 and
, with  and . Larsen et al. estimate parameters by
maximizing the marginal likelihood:
where ϕ(·, m, s2) denotes the density of a normal random variable with mean m and variance
s2. We use the convention that . The parameter of interest is β1, which can
be interpreted as the difference in mean AOO between consecutive generations of the same
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family. In the original paper, the authors find a highly significant effect from anticipation,
with  corresponding to the fixed effect of generation.
2.2 Birth cohort adjustment
We first describe the adjustment strategy we adopted to create the pseudo-AOO data upon
which the final models were built. As mentioned in Section 1, without adjusting for secular
changes in diagnostic techniques and lifestyle, the change in AOO between consecutive
generations is the cumulative effect of these changes and any anticipatory effect which may
be present. Including a “year of birth” effect in order to capture these secular changes does
not solve the problem, as corresponding parameters are only weakly identifiable due to ill-
conditioning of the design matrix. A stratified-by-birth-cohort analysis lacks statistical
power. As an alternative, this cohort effect may be estimated from external historic data. The
Nordic Cancer Registries (NORDCAN, Engholm et al., 2010) provide incidence, mortality
and prevalence data on 41 major cancers in the Nordic countries. We estimated the change
in AOO between five-year birth cohorts via a two-step process.
First, we accumulated cohort-specific incidence rates of colorectal cancer (and, for women,
endometrial cancer, the other major Lynch-related cancer) over five-year periods beginning
in 1943, the earliest data available, and ending in 2008. Thus, for a single five-year birth
cohort, its estimated hazard function for cancer diagnosis was piecewise-linear, changing at
five year knots. Web Figure 1 gives a sample plot of the incidence rates by birth cohort for
males. We assumed that there was no hazard for cancer diagnosis before age ten and that it
remained constant after age 85. There was also some missing information; e.g., when the
Registries began in 1943, there was no information on previous incidence rates for the
`1869–1873' birth cohort (70–74 years old at that time). We filled in these missing values
with the mean of the age-specific hazards for the next five birth cohorts, `1874–1878',…,
`1894–1898', when they were 70–74 years old.
Second, we simulated each Danish birth-cohort and exposed it to its cohort-specific hazard.
An estimate of each cohort size was obtained from NORDCAN. We then fitted a single
survival model with these simulated times-to-event data (Sl, say, for the lth individual) with
the corresponding birth cohort as an ordinal covariate. Namely, Sl = γ cohortl + εl,
. The cohort variable is defined as cohortl = 0, if the lth subject is born in the
reference cohort 1959–63, cohortl = 1 if the lth subject is born in 1964–1968, cohortl = −1,
if the lth subject is born in 1954–58, and so on for each five-year cohort. We fitted this trend
model stratified by gender:  was −0.215 years for males and −0.176 years for females. Of
the two primary sources of variability in these estimates (due to simulation variability and
the comprehensiveness of the registry), only the former was quantifiable: 50 simulations saw
standard deviations of about 0.008 in these estimates. Given the scale of the variables, this
uncertainty was ignored in all subsequent analysis.
Returning to the primary dataset under consideration, to adjust for these estimated secular
trends, we transformed the data corresponding to the jth member of the ith family as
 and  (under the convention that ∞
remains unchanged) for males, and similarly for females. For an observed (censored) event
time, we can interpret  as the AOO (time of censoring) if that person had experienced the
medical technology and lifestyle of someone born in the reference cohort. We now present
four alternative models using the adjusted AOO data  as our response.
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2.3 Alternative Models and Likelihood
Recalling the general structure of (1), the common elements of each model are given as
follows. , so that the parameter of interest becomes b1i, the
random slope associated with genij. We interpret b1i as the change in AOO (in years)
between consecutive generations of the ith family after adjusting for cohort effects and other
covariates. We use a mixture model for the random effects, namely,
(2)
Let di denote cluster membership, so that, for di ε {1,–, k}, bi|di, μdi, . The
error distribution is assumed to be  heavy tails account for outliers we found in
preliminary analyses. In all analyses, Tij is the outcome, as in (1). This choice of
untransformed outcome and t-residuals provides significantly improved fit over a model
with log-transformed AOO and normal residuals. Moreover, the estimated parameters can be
directly interpreted in terms of the number of years increse/decrease in AOO. The unique
specifications corresponding to each of the four random effects models are as follows.
Model 1 (M1): Single component multivariate normal—The fixed effects are given
by:  (1[maleij], 1[muti = hMLH1], 1[muti = hMSH2]) × (β1, β2, β3)⊤. In (2), k = 1, so
. Relative to Larsen et al., this model relaxes the constraint of a common
anticipation effect across families.
Model 2 (M2): Three distinct multivariate normals assigned by measured
mutation subtype—The fixed effects, . Additionally, di = 1[muti =
hMLH1] + 2 × 1[muti = hMSH2] + 3 × 1[muti = hMSH6], which implies that cluster
membership is known, based on the MMR mutation subtype of each family. Thus, rather
than just shifting the mean AOO, as in M1, the mutation subtypes also differ (potentially) in
the slope corresponding to genij.
Model 3 (M3): A finite mixture of multivariate normals—As in M1, the fixed effects
are  (1[maleij], 1[muti = hMLH1], 1[muti = hMSH2]) × (β1, β2, β3)⊤. For the mixture
components, both k and {di} are unknown parameters. This is a more flexible version of
M1; mutation subtypes play the same role of shifting the mean AOO, but the distribution of
the random eFFects is not forced to normality.
Model 4 (M4): An infinite mixture of multivariate normals—The fixed effects are as
in M1 and M3, but bi is given a Dirichlet Process mixture (DPM) of normals prior,
described by the following hierarchy:
α is a precision parameter and G0(μ, Σ) is the normal-Wishart base distribution (Escobar and
West, 1995). Prior specification on α and G0 is described in the next section. M3 and M4 are
similar, the primary difference in interpretation being that the latter allows for the existence
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of clusters in the population not found in the study sample, admitting an additional level of
uncertainty. Note the increasing order of flexibility as we go from M1 to M4.
We consider the joint likelihood of the data and the random effects as the basis of our
inference. The contribution of the ith family to this joint likelihood is given by,
(3)
τ(·, m, s2, ν) gives the density of a t-distributed scalar with location m, scale s and ν degrees
of freedom, ϕ2(·, M, S) denotes the density of a bivariate normal (BVN) vector with mean
vector M and variance matrix S, and . Quadrature or Monte Carlo methods
could be used to integrate the random effects in (3) so as to maximize the marginal
likelihood, but a hierarchical Bayesian approach is conceptually and computationally much
simpler for the proposed latent mixture models.
2.4 Priors
We next specify the prior distributions on model parameters. In all cases, β is given a
uniform prior on  and σ2 is Gamma with shape 1 and rate 0.01.
For M1–M3, μℓ|ξ, κ is BVN with mean ξ and precision matrix κ. The hyperprior on ξ is
uniform on , and κ is assumed Wishart with 2 degrees of freedom (df) and scale matrix
(2I2×2)−1. Finally,  is Wishart with 8 df and scale matrix (2Ψ)−1, and the hyperprior
on Ψ is Wishart with df 2g and scale matrix (2h)−1. We vary g, h to assess prior sensitivity.
M3 requires two additional priors. The number of mixing components k is assumed a priori
Poisson with mean 3, truncated at 20, and the mixing probabilities {π1, …, πk}|k are
assigned a non-informative discrete Dirichlet (1, 1, …, 1) prior. Inference on k is sensitive to
the prior on κ (Richardson and Green, 1997), but, since we are primarily interested in
exploring heterogeneity rather than identifying distinct familial clusters, fitting more
components than necessary is not a concern in the current application.
For M1–M3, it remains to select g and h. This far down the hierarchy, they cannot be
intuited or made sufficiently vague. Moreover, it seems plausible that inference on the
random effects could be sensitive to g and h; thus we consider several prior structures. For
M3, larger values on the diagonals of h favor many small variance components, yielding
undesirable spikes in the density of the random effects. Keeping this in mind, we set g1 = 2
and h1 = diag(0.06, 0.12); sampling values of Σℓ from this prior shows that the middle 99%
of the density is approximately (0.63, 74.62) and (0.36, 37.94) for he diagonal components,
wide intervals that avoid zero. As a sensitivity analysis, we also looked at two other priors:
g2 = 1 and h2 = diag(0.03, 0.06), which flattens the prior density on Σℓ, and g3 = 2 and h3 =
diag(0.1, 0.3), which puts more mass closer to zero-values.
For M4, we assume a Gamma prior on α with shape 2 and rate 0.5. This induces a prior
mode for the number of clusters k at 10, with about 80% of the prior mass on k < 20. For the
parameters of the normal-Wishart base measure G0(μ, Σ), Σ−1|A is Wishart with 5 df and
scale matrix A−1 and μ|ξ, κ0, Σ is normal with mean ξ and scale matrix . Finally, ξ is
normal with mean (50, 0) and variance diag(30, 10), κ0 is Gamma with shape 0.05 and rate
0.05, and A|B is Wishart with 5 df and scale matrix B−1. While B roughly corresponds to h
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above, a direct correspondence can not be drawn between the two hyperparameters. We
present results under B = diag(3, 6) and evaluate sensitivity to this prior choice.
2.5 Posterior Sampling
We take a Gibbs sampler/data augmentation approach to handle the censored data likelihood
(Tanner and Wong, 1987). The algorithm changes between the four models because k and
{di} are known for M1 and M2 but not M3 or M4. This also implies that the dimension of
the parameter space in M3 and M4 can change across iterations; in the finite mixture case of
M3, we use the MCMC scheme developed by Stephens (2000), whereas for M4, we use
sampling algorithms proposed by Neal (2000) implemented in the DPpackage in R (Jara,
2007). See Web Appendix A for details of the sampling strategy and full conditionals.
For each pairwise combination of {M1, M2, M3} with {{g1, h1}, {g2, h2}, {g3, h3}} and
also M4, we run two independent chains with dispersed starting values. The first 10000
iterations are discarded, with every 10th iteration stored thereafter until 10000 such
iterations per chain are collected. Combining the two chains gives 20000 draws from the
posterior distribution. Convergence is assessed via trace plots and monitoring the value of
the potential scale reduction factor (Gelman and Rubin, 1992).
3. Model Comparison and Assessment
3.1 Model Comparison
Quantitative assessments of model fit and predictive ability of the candidate models are
carried out by considering the following three criteria.
Deviance Information Criterion (DIC)—(Spiegelhalter et al., 2002; Celeux et al.,
2006). The notion of calculating DIC is not translatable to the case of the DPM model (M4),
which has an infinite-dimensional parameter space with unbounded model complexity; the
following discussion is relevant to M1–M3. For a generic model, given data y, parameter
vector θ, and probability model f(y|θ), Spiegelhalter et al. propose DIC = −4Eθ|y ln f(y|θ) + 2
ln , which is the sum of the posterior mean deviance, −2Eθ|y ln f(y|θ), and the
penalty term, −2Eθ|y ln f(y|θ) + 2 ln , where  is some posterior estimate of θ,
usually the posterior mean. The penalty term is meant to approximate the dimensionality of
the parameter space. Once a focus has been identified, the posterior mean deviance can be
estimated by a Monte Carlo average of the log-likelihood, but because of the choice in ,
there is not a consentient definition of DIC for hierarchical models, especially in the
presence of random effects and missing data.
There are additional considerations to be made in our case study. Counting k and {di}
towards model complexity via the penalty term is asymmetric, as they are known in M1 and
M2 and would therefore not contribute to the penalty term, but unknown in M3. M3's DIC
should be penalized for its number of components by way of estimating multiple mean
vectors and variance matrices; including k and {di} would doubly-penalize it. This decision
is similar to the EM approach to mixture problems, in which the number of clusters and
cluster membership are treated as missing data in the complete likelihood.
Consequently, there is missing data on both sides of the conditioning bar in the likelihood:
(3) is really the joint density of  and U1 ≡ {bi} (the latter being unobserved),
and U2 ≡ {k, {di}} is observed in M1 and M2 but latent in M3.
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Let θ denote all other variables in (3), so that the likelihood can be written as Πi Li = f(y, U1|
U2, θ). Celeux et al. (2006) provides an excellent treatment of DIC in the presence of
missing data and random effects but only considers likelihoods with one type of U (either on
the left of the conditioning bar [the “complete DIC”] or the right [the “conditional DIC”] but
not both). It is a natural extension to hybridize the two corresponding DICs from this paper
(DIC4 and DIC8) to obtain,
which we call the hybrid “conditional-complete DIC”. This definition avoids the unwanted
behavior of doubly-penalizing M3 for estimating k and {di}, as the expectation over U2
remains outside of the the log in both terms. The only quantity which is not trivial to
estimate via MCMC output is Eθ|y,U1,U2 θ, the conditional expectation of θ for arbitrary
values of U1 and U2. We instead approximate this quantity at each step in the Gibbs sampler
with the mean of the conditional distribution.
Conditional Predictive Ordinate (CPO)—This is a cross-validation assessment
originally proposed by Geisser (1980). When , it is defined for person (i, j) as
, where data(−[ij]) means “data for all but person (i, j)”.
Similarly, when , . Thus, a large CPO indicates good
fit. The log of the pseudo-marginal likelihood (LPML) is given by Σij log CPOij and is a
summary of the overall model fit. Alternatively, inspecting the log of the ratio of CPOs from
two competing models shows the the preferred model for each individual. Let η represent all
variables in the likelihood. For the observed survival times, Gelfand and Dey (1994) propose
the approximation , using the Monte Carlo sample to estimate
the expectation. A similar technique can be employed for the censored survival times,
replacing densities with probabilities, as introduced in Hanson (2006).
Brier score—This measure can be used both for model comparison and verification. It is
defined as the average squared difference between the current survival probabilities at time t
and the current status; thus a higher score is worse. Graf et al. (1999) redefine it in the
presence of right-censoring, the contribution of person (i, j) at time t being
where  is the estimated survivor function of person (i, j) (averaged over all Monte Carlo
simulations), and  is the Kaplan-Meier estimated distribution of censoring times. The
integrated Brier score is given by averaging BSij(t) over i and j and integrating over all event
and censoring times. We divide each model's integrated Brier score by a reference score
(that from plugging in ), so that any model that improves upon equivocality is in
[0, 1]. We call this a scaled integrated Brier score (SIBS).
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4. Results applied to Danish HNPCC Data
4.1 Posterior Inference
Features of densities associated with random anticipation effects—We present
results under the prior specification {g, h} = {g1, h1} and B = diag(3, 6) (placed on the
variance components). The top panel of Figure 1 provides the posterior predictive density of
the anticipation random effect its interpretation being the predicted density of b1i for a
newly-introduced pedigree. For M2, each mutation group is separate as cluster membership
is pre-specified. For M3 we marginalize over the mixture components. The density
associated with M4 is a kernel density estimate using new draws of b1i from each converged
iteration of the chain. Details are provided in Web Appendix A.
While M3 shows evidence of multiple clusters (58% of the MCMC iterations estimated k >
1), the impact is only to fatten the tails of M1. M4 has even heavier tails (k exceeded one
83% of the time); the mean anticipation effect in M4 is slightly smaller than M1 and M3. If
there are multiple modes to the mixture density, there is not enough information to
differentiate between them. With assigned cluster membership, M2 differentiates hMSH6
from the other two mutations. The mean anticipation effect is just greater than 1 year for
hMSH6, compared to about 2.5 years for the other mutations, and the distribution has wider
spread. Note also that, if no random slope was needed, all these densities would be peaked
and concentrated and show no variation, thus there is evidence supporting a random (and not
fixed) slope model for generation.
The bottom panel of Figure 1 gives kernel estimates of the posterior density of the random
slope corresponding to generation for the largest family from each mutation subtype in our
study. For the hMSH2 family, the mean anticipation effect is similar between M1–M4, and
only slight differences arise in the hMLH1 family. However, there are differences between
the models for the hMSH6 family; the estimated mean effect of anticipation is smaller in M2
and M4 as compared to M1 or M3. M4 again shows the largest variability in all cases.
Posterior density estimates for all families are given in Web Figure 2.
Figure 2, presents estimated posterior distribution functions corresponding to b1i, i = 1, …,
124, in terms of P(b1i < c) for differing values of c. The value c signifies the decrease in
number of years in AOO for successive generations. A significant probability of the random
slope being less than −2.0 years say, indicates earlier age of onset in successive generations
in that family. We note substantial heterogeneity in these values across families within each
mutation subtype. There is more uncertainty in ordering of the families under M4 which is
to be expected from the DPM specification. This plot again reiterates the need for a family-
specific estimate of anticipation even within a given mutation type.
Parameters of the distributions associated with the random effects—Table 2
presents numerical summaries of the posterior predictive density and moments of the
posterior density of the hyperprior parameters corresponding to the random intercept and
slope, (b0i, b1i). The results are summarized in terms of the median (p50) and equi-tailed
95% credible intervals (p2.5, p97.5) based on the draws from the corresponding distributions.
Note that mutation subtype is excluded from the fixed covariates in M2, so b0i and
Mean(b0i) under M2 are not directly comparable to the other models. The estimate of
anticipation, as measured by the posterior distribution of the hypermean of the random
effects, is identical under M1 and M3 (−2.3 yrs with CI [−3.5,−1.1] yrs) whereas M4
provides a similar estimate with wider CI (−2.5 yrs with CI [−5.6,0.6] yrs). The estimates
obtained from M2 illustrates a stronger anticipation effect in hMLH1 and hMSH2 families
(−2.8 yrs, CI [−4.3,−1.2] yrs for hMLH1 and −2.5 yrs, CI [−3.8,−1.0] yrs for hMSH2) when
compared to hMSH6 (−1.0 yrs, CI [−3.3,1.1] yrs). Similar estimates are obtained from the
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posterior predictive distribution, but with larger uncertainty owing to individual observations
being more variable than the mean estimate. Estimates of the random effects' variance-
covariance hyperparameters in Table 2 (last block) are sensitive to prior choices on Σ under
the DPM in M4 and produce different results than M1–M3.
Fixed effects estimates—The top panel in Table 2 presents fixed effects estimate
corresponding to gender and mutation status (except M2). There is evidence of a later age of
onset for males whereas mutation subtype is also a significant factor with hMLH1 and
hMSH2 showing earlier mean AOO than hMSH6. However, the effect of mutation status and
familial random effects have to be examined and interpreted jointly for each family.
Prior Sensitivity—For M1–M3, results from all three prior specifications were quite
similar (results not tabulated). For M1 and M3, the difference between any two priors in the
p50 estimate of a newly observed b1i was never more than 0.07, a small number given the
scale. This was also observed in the hMLH1 and hMSH2 subtypes under M2; for hMSH6,
the p50 estimates were −1.04, −0.86, and −0.96 for the three prior specifications. Credible
intervals for M1, M2, and M3 were similar between the first two priors and narrower under
{g3, h3}. The DPM in M4 required a more informative prior on the variance components in
Σ; vague priors yielded larger credible intervals. In general, M4 exhibits more variability in
estimating the hyperparameters on the random effects. The results were robust to prior
choice on α.
Clinical Application—Affected families will likely be interested in the family-specific
extent of anticipation. Consider the hMSH2 family in the bottom panel of Figure 1, say i = i′.
Pr(b1i′ < 0) = 0.86 and Pr(b1i′ < −2) = 0.39 for M1 under {g1, h1} (M2 and M3 make
statements within 0.03 of this probability). This means that the probability that there is some
anticipation effect is 0.86 and the probability that the effect from anticipation is at least 2
years is about 0.39. On the other hand, for the hMSH6 family in the Figure (i = i″), Pr(b1i″ <
0) = 0.89 for M1 but is 0.63 for M2, and Pr(b1i″ < −2) = 0.42 for M1 but is only 0.16 for
M2. Thus, at the level of individual families, the extent of anticipation does depend on the
assumed model. Robust choices evoke more confidence in obtained results. However, how
strong an anticipation effect is necessary to change prophylactic care for a given family
needs to be clinically determined.
4.2 Model Comparison and Assessment
Table 3 provides results from the quantitative comparison techniques discussed in Section 3
under the three prior specifications. Using DIC, there is no consistently preferred model.
Estimates of deviance fluctuate markedly between priors. On the other hand, the penalty
components are relatively stable, even under M3, with a latent “true” number of parameters.
For LPML, differences between M1–M3 are small, but M1 is actually preferred for all three
priors; variation of LPML between and within priors was less than that of DIC. Focusing on
individuals, Figure 3 gives the log of the ratio of CPOs comparing M1 to M2 under {g1, h1}
for each individual. This model-to-model comparison is particularly interesting because the
general trend is that hMSH6 individuals with late AOOs are fit relatively better by M1 (the
log of the ratio being greater than 0) but that M2 offers an improvement in fit for the less
extreme event times. We saw similar results when comparing M2 to M3. For hMLH1 and
hMSH2 families, results across models are very similar. In terms of LPML, M4 is least
favored across the models.
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Relative to LPML, the order of preferred models is reversed under SIBS. The scale of the
between-model differences and between-prior variability is about the same as LPML. In
contrast to LPML, M4 slightly improves upon the other models.
For aggregate measures of prediction, there is little difference between models, supporting
the findings of McCulloch and Neuhaus (2010). As for individual predictions, there is
sensitivity to model choice (Figure 3), and no model is uniformly preferred.
5. Discussion
In this paper we develop the first Bayesian approach to assess genetic anticipation, a
problem for which interest lies primarily in prediction of random effects governed by a
biologically-plausible non-normal distribution (Lynch et al., 2006). We see additional
evidence of its necessity through our work, e.g., Figure 2 indicates substantial familial
heterogeneity. We evaluate candidate models which cover a wide range of distributions for
the random effects.
The relative survival-type adjustments using historic data provide a systematic approach to
adjust for secular trends in AOO, an issue many papers on genetic anticipation have
grappled with. While we have tried to mitigate these effects by using external data on all
incident cases of colorectal and endometrial cancer, increased awareness of Lynch syndrome
may still mean some of the anticipation is diagnostic in nature and not only genetic.
After adjusting for secular trends, there remains evidence of anticipation at both the
population and the familial level. The population-level effect size is about 2.5 years across
models, 0.5 years less than the original paper (Larsen et al., 2009). The model which
constrains cluster membership (M2) identifies one mutation subtype, hMSH6, to be
considerably different from the other two. The hMSH6 mutation had the fewest families
(22), yielding less precision compared to the other subtypes. It would be worthwhile to posit
mechanistic reasons for heterogeneities within hMSH6 families.
The Bayesian simulation methods we use provide direct posterior draws of all parameters,
allowing for model assessment and posterior predictions for clinical quantities of interest. As
we saw, successfully answering the question, “What is the extent of anticipation in a
particular family?”, depends crucially upon properly modeling the anticipation coefficient as
well as deciding upon a clinically relevant definition of anticipation.
As a statistical point of interest, this study provides a good forum for the evaluation of
Bayesian model comparison techniques. We have a likelihood in which calculation of DIC
is not straightforward with current methods. We define a new hybrid complete-conditional
DIC, appropriating the ideas of Celeux et al. (2006). It is worthwhile to investigate further
this sensitivity of the hybrid DIC to prior specification. To our knowledge, the scaled
integrated Brier score has not been used previously in Bayesian analysis of censored data.
The methods and analytic approaches that we develop provide statistical insight into genetic
anticipation and also facilitate application in clinical situations. These results are only
readily applicable to high-risk Lynch families and generalization to a different population
would require further correction for ascertainment bias.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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The top panel presents posterior predictive density of a new pedigree, not present in our
dataset, under models M1–M4. The bottom panel presents kernel estimates of the posterior
density of three largest families present in our dataset, one from each mutation subtype,
under models M1–M4.
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Estimated posterior distribution functions of b1i, namely  for i = 1, …, 124, all
families in our dataset. The y-axis gives the threshold in years, and the grayscale reflects the
corresponding probability. Families (along the x-axis) are ordered first by mutation status
(43 hMLH1, 59 hMSH2 and 22 hMSH6 families are represented) and then by the posterior
median of b1i as predicted by M1 within each mutation subtype. c signifies the reduction in
number of years in AOO for successive generations. Thus a substantial probability of falling
below a negative threshold value indicates evidence of anticipation for that family.
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The logarithm of the ratio of CPOs for M1 (CPOM1) to M2 (CPOM2) by most recent age.
Individuals are grouped by family mutation and stratified by the censoring indicator. Values
greater than 0 favor M1.
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Table 1
Descriptive summary of the Danish HNPCC data, containing 43 hMLH1 families, 59 hMSH2 families, and 22
hMSH6 families. The first column denotes total numbers of individuals, the second column gives numbers of
individuals who have been diagnosed with a Lynch Syndrome (LS) cancer, and the third and fourth columns
give summary statistics corresponding to the ages of onset (AOO) of affected individuals.
# Subjects # LS cancers mean (AOO) sd (AOO)
Males 392 263 47.0 13.0
Females 424 305 46.6 11.7
gen= 1 196 190 53.0 11.9
gen = 2 345 274 45.2 11.0
gen = 3 234 100 40.0 11.0
gen = 4 41 4 25.0 13.6
hMLH1 279 194 45.4 12.8
hMSH2 402 289 46.3 11.5
hMSH6 135 85 51.6 13.1
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Table 2
Numerical summaries of densities associated with random slopes and intercept estimates. The median (p50)
and middle 95% quantiles (p2.5, p97.5) based on the generated draws from the corresponding distribution are
presented. All results correspond to prior {g, h} = {g1, h1} as described in the text. The b0i and b1i columns
correspond to the posterior predictive distributions for a new random slope and intercept, respectively. The
Mean, Var and Cov columns are derived from the (marginalized over cluster configurations, for M3 and M4)
posterior density estimates of the hyperprior parameters corresponding to the random effects.
p50(p2.5, p97.5)
Fixed Effect Parameters β1 Gender β2 hMLH1 β3 hMSH2 σ Error Scale
M1 1.5 (−0.3,3.2) −6.8 (−9.7,−3.9) −6.4 (−9.2,−3.7) 9.8 (9.1,10.5)
M2 1.5 (−0.3,3.2) 9.8 (9.1,10.5)
M3 1.5 (−0.3,3.3) −6.6 (−9.6,−3.7) −6.3 (−9.1,−3.5) 9.8 (9.1,10.5)
M4 1.5 (−0.3,3.3) −6.3 (−9.8,-2.6) −6.1 (−9.4,-2.6) 9.6 (8.9,10.4)
Random Effect Parameters b0i b1i Mean[b0i] Mean[b1i]
M1 57.3 (50.9,63.9) −2.3 (−5.7,1.0) 57.4 (54.0,60.7) −2.3 (−3.5,−1.1)
M2 hMLH1 51.5 (44.9,58.3) −2.8 (−6.2,0.7) 51.5 (48.4,54.7) −2.8 (−4.3,−1.2)
M2 hMSH2 51.3 (44.9,57.8) −2.4 (−6.1,1.1) 51.4 (48.3,54.2) −2.5 (−3.8,−1.0)
M2 hMSH6 54.0 (46.5,62.2) −1.1 (−5.3,3.0) 53.9 (49.9,59.1) −1.0 (−3.3, 1.1)
M3 57.2 (50.4,64.2) −2.3 (−6.0,1.2) 57.2 (53.8,60.6) −2.3 (−3.5,−1.1)
M4 57.2 (44.8,69.7) −2.5 (−10.2,5.2) 57.3 (51.5,62.9) −2.5 (−5.6, 0.6)
Random Effect Variance Parameters Var[b0i] Cov[b0i, b1i] Var[b1i]
M1 5.6 (0.8, 26.1) −2.2 (−12.0, 0.4) 1.9 (0.3, 7.2)
M2 hMLH1 6.0 (0.7, 31.0) −2.2 (−12.0, 0.5) 1.8 (0.3, 7.0)
M2 hMSH2 6.0 (0.7, 27.4) −2.5 (−13.4, 0.3) 2.1 (0.3, 8.5)
M2 hMSH6 6.4 (0.7, 39.6) −2.5 (−18.6, 0.5) 2.1 (0.3,11.7)
M3 6.0 (0.7, 25.7) −2.4 (−11.9, 0.3) 2.0 (0.3, 7.2)
M4 19.0 (2.5,100.9) −6.7 (−41.4,11.9) 7.0 (1.0,72.6)
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Table 3
Assessment of M1–M3 under 3 priors placed on the variance of the mixture components of the random effects
distribution: {g1, h1} avoids values close to 0, {g2, h2} is weaker and “flattens” the prior density relative to
{g1, h1}, and {g3, h3} pushes the density closer to 0. DIC is 'Deviance Information Criterion', pD is the penalty
term (an estimate of model complexity), LPML is the logarithm of the pseudo-marginal likelihood, and SIBS
is the scaled integrated Brier score. The results for M4 correspond to the prior specification described in the
text. In each column, smaller is better.
Prior {g1, h1} {g2, h2} {g3, h3}
Model DIC (pD)
M1 2911 (5.9) 2664 (6.2) 2818 (6.2)
M2 2917 (12.3) 2653 (12.6) 2822 (12.6)
M3 2902 (9.4) 2660 (9.7) 2806 (9.4)
-LPML
M1 1041.2 1038.1 1039.8
M2 1042.7 1038.2 1041.0
M3 1042.2 1039.9 1040.9
M4 1064.6
SIBS
M1 0.2627 0.2651 0.2641
M2 0.2625 0.2653 0.2641
M3 0.2618 0.2638 0.2632
M4 0.2510
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